Systemic mastocytosis, in the context of a deleterious germline SDHC variant, treated with ripretinib

• Sara Saheb Kashaf, MPhil,
• Lucy A. Godley, MD, PhD,
• Angad Chadha, MD,
• Jason B. Waldinger, MD

Affiliations

Sara Saheb Kashaf, MPhil

Pritzker School of Medicine, the University of Chicago, Chicago, Illinois

Lucy A. Godley, MD, PhD

Section of Hematology/Oncology, Department of Medicine and Human Genetics, the University of Chicago, Chicago, Illinois

Angad Chadha, MD

Section of Dermatology, Department of Medicine, the University of Chicago, Chicago, Illinois

Jason B. Waldinger, MD

Pritzker School of Medicine, the University of Chicago, Chicago, Illinois; Division of Dermatology, Department of Medicine, NorthShore University & Health System, Evanston, Illinois; Correspondence to: Jason B. Waldinger, MD, Clinical Assistant Professor of Dermatology, University of Chicago, Division Head, Division of Dermatology, Department of Medicine, NorthShore University & Health System, 71 Waukegan Rd., Suite 700, Lake Bluff, IL 60044.